Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats-Reference-Cited by-同舟云学术

Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed rats

Published:2021-02 Issue: Volume:164 Page:105357
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Di Bartolomeo Martina,Stark Tibor,Maurel Oriana Maria,Iannotti Fabio Arturo,Kuchar Martin,Ruda-Kucerova Jana,Piscitelli Fabiana,Laudani Samuele,Pekarik Vladimir,Salomone Salvatore,Arosio Beatrice,Mechoulam Raphael,Maccarrone Mauro,Drago Filippo,Wotjak Carsten T.,Di Marzo Vincenzo,Vismara Matteo,Dell’Osso Bernardo,D’Addario Claudio,Micale Vincenzo

Funder

National Institute of Mental Health

Masarykova Univerzita

Università di Catania

Publisher

Elsevier BV

Subject

Pharmacology

Reference97 articles.

1. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction;Ayalew;Mol. Psychiatry,2012

2. Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations;European Network of National Networks studying Gene-Environment Interactions in Schizophrenia (EU-GEI);Schizophr. Bull.,2014

3. Cannabis and psychosis/schizophrenia: human studies;D’Souza;Eur. Arch. Psychiatry Clin. Neurosci.,2009